Discontinuation report M-RANITIDINE

Last updated on 2020-09-17 History
Report ID 124442
Drug Identification Number 02473534
Brand name M-RANITIDINE
Common or Proper name Ranitidine
Company Name MANTRA PHARMA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) RANITIDINE
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-09-14
Remaining supply date 2020-09-14
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1000 RUE DU LUX SUITE 201
BROSSARD, QUEBEC
CANADA J4Y 0E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-09-17 French Compare
v4 2020-09-17 English Compare
v3 2020-09-17 French Compare
v2 2020-09-17 English Compare
v1 2020-09-17 English Compare

Showing 1 to 5 of 5